China-Biotics begins trial production of probiotics

The Company added eight new bulk additive customers in September and October, bringing its total number of bulk additive customers to 24.

 

The newly signed customers are mainly engaged in manufacture of dairy, nutritional supplement, and animal feed products.

 

The trial production of Phase I has recently begun at its new state-of-the-art production facility in Qing Pu Industrial Park in Shanghai. Phase I has a production capacity of 150 metric tons of probiotics per year.

 

"We are delighted to begin trial production at our new facility and start the second phase of our capacity expansion, which we expect to complete by the end of the year," said Jinan Song, China-Biotics’ Chairman and Chief Executive Officer.

 

"We continue to experience significant demand for our probiotics products and our pipeline of potential new bulk additive customers remains strong. As a result, we expect to achieve revenue growth of at least 50% during the 2010 fiscal year."

 

China-Biotics manufactures biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements.

 

Through its wholly owned subsidiary, Shanghai Shining Biotechnology, the company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand.

 

Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang.

 

Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market.

 

For more information visit China-Biotics website.